So far 15 patients underwent surgery in the proof-of-concept study, according to an Oct. 17 news release.
“This is an important goal for the study: addressing the need for non-narcotic pain management therapy earlier on to avert the need for opioids,” Rohan Lall, MD, a co-investigator on the study, said in the release. “If the SynerFuse e-TLIF procedure proves effective at lowering post-operative pain levels, as early indications have suggested, we may have a new treatment strategy that potentially saves the healthcare system billions of dollars and improves pain management outcomes.”
At the Becker's 23rd Annual Spine, Orthopedic and Pain Management-Driven ASC + The Future of Spine Conference, taking place June 11-13 in Chicago, spine surgeons, orthopedic leaders and ASC executives will come together to explore minimally invasive techniques, ASC growth strategies and innovations shaping the future of outpatient spine care. Apply for complimentary registration now.
